Alcon IQ approved in US
The aspheric AcrySof IQ Toric intraocular lens (Alcon Inc) has been approved by the FDA, and will shortly be available to provide improved distance vision to patients with cataract and astigmatism.
The aspheric AcrySof IQ Toric intraocular lens (Alcon Inc) has been approved by the FDA, and will shortly be available to provide improved distance vision to patients with cataract and astigmatism.
The AcrySof Toric was initially introduced in 2005. Its acrylic single-piece design provided good rotational stability in addition to the more accurate prediction of power outcomes the lens made possible. The aspheric optic of the new lens will allow for increased contrast sensitivity, and its thinner profile makes it suitable for micro-coaxial surgical techniques.
Alcon plans to launch the AcrySof IQ Toric at the 2009 meeting of the American Society of Cataract and Refractive Surgeons (ASCRS), which will be held in San Francisco, California from April 3–8.
Newsletter
Join ophthalmologists across Europe—sign up for exclusive updates and innovations in surgical techniques and clinical care.
